PGI3 RISK OF UPPER GASTROINTESTINAL ADVERSE EVENTS AND THE EFFECT OF ACID-SUPPRESSIVE THERAPY IN PATIENTS RECEIVING ACETYLSALICYLIC ACID FOR CARDIOVASCULAR RISK MANAGEMENT
2012 ◽
Vol 13
(1)
◽
pp. 27-35
◽
2017 ◽
Vol 36
(6)
◽
pp. 1387-1393
◽
2017 ◽
Vol 23
(10)
◽
pp. 1471-1476
◽
Keyword(s):
2018 ◽